Notably, recent studies have reported that RS malignant cells exhibit reduced BCR signaling compared with CLL cells, suggesting that alternative mechanisms may sustain NF-κB activity in RS [21]. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.